文献速递医院感染防控新发突发、热带与寄生虫病

院内mNGS诊断下呼吸道感染的临床效用及宿主免疫应答分析

Clinical Utility of In-house Metagenomic Next-generation Sequencing for the Diagnosis of Lower Respiratory Tract Infections and Analysis of the Host Immune Response.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该前瞻性观察研究纳入2019年北京大学人民医院93例下呼吸道感染(LRTI)患者和69例无LRTI患者,比较支气管肺泡灌洗液(BALF)mNGS(DNA和RNA)与传统微生物学检测。mNGS检出率65%,灵敏度66.7%、特异度75.4%,对病毒和真菌检出优于传统方法;宿主转录组数据有望辅助LRTI诊断。

要点

  • BALF mNGS(DNA和RNA)对LRTI病原体检出率65%,高于培养(20%)和传统微生物学(35%)。
  • 以复合参考标准为金标准,mNGS灵敏度66.7%、特异度75.4%、阳性预测值78.5%、阴性预测值62.7%。
  • 宿主转录组差异基因与感染免疫应答、病毒转录及干扰素-γ通路、穿孔素1和T细胞受体B可变9相关。

核心结论

  • 宏基因组DNA和RNA测序可识别多种LRTI病原体,对病毒和真菌的灵敏度更高。
  • 院内mNGS平台约2个工作日周转,在临床可能可行,宿主转录组数据有望用于LRTI诊断。

研究设计与样本

  • 前瞻性观察研究,2019年连续纳入北京大学人民医院93例LRTI患者和69例无LRTI患者。
  • 采用BALF标本,进行mNGS(DNA和RNA)与传统微生物学检测,并比较宿主转录组。

主要发现

  • 93例LRTI中,培养、全部微生物学检测和mNGS分别检出20%、35%和65%的明确或可能病原体。
  • 院内BALF mNGS平台周转时间约2个工作日,检出病毒和真菌多于其他方法。
  • 以复合参考标准为金标准,mNGS灵敏度66.7%、特异度75.4%、阳性预测值78.5%、阴性预测值62.7%。
  • LRTI相关差异表达基因与感染免疫应答相关,病毒性LRTI相关基因与病毒转录和干扰素-γ应答通路相关,结核相关基因与穿孔素1和T细胞受体B可变9相关。

临床怎么用

  • 对传统微生物学检测阴性的LRTI,可考虑BALF mNGS(DNA和RNA)以提高病毒和真菌检出。
  • mNGS结果需结合复合参考标准和临床综合判断,其阴性预测值有限。
  • 宿主转录组特征可能辅助区分LRTI类型,但尚需进一步验证。

局限性

  • 单中心研究,样本量有限(93例LRTI和69例无LRTI)。
  • mNGS灵敏度66.7%、特异度75.4%,阴性预测值62.7%,诊断性能并非完美。
  • 宿主转录组发现需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Only few pathogens that cause lower respiratory tract infections (LRTIs) can be identified due to limitations of traditional microbiological methods and the complexity of the oropharyngeal normal flora. Metagenomic next-generation sequencing (mNGS) has the potential to solve this problem. METHODS: This prospective observational study sequentially enrolled 93 patients with LRTI and 69 patients without LRTI who visited Peking University People's Hospital in 2019. Pathogens in bronchoalveolar lavage fluid (BALF) specimens were detected using mNGS (DNA and RNA) and traditional microbiological assays. Human transcriptomes were compared between LRTI and non-LRTI, bacterial and viral LRTI, and tuberculosis and nontuberculosis groups. RESULTS: Among 93 patients with LRTI, 20%, 35%, and 65% of cases were detected as definite or probable pathogens by culture, all microbiological tests, and mNGS, respectively. Our in-house BALF mNGS platform had an approximately 2-working-day turnaround time and detected more viruses and fungi than the other methods. Taking the composite reference standard as a gold standard, it had a sensitivity of 66.7%, specificity of 75.4%, positive-predictive value of 78.5%, and negative-predictive value of 62.7%. LRTI-, viral LRTI-, and tuberculosis-related differentially expressed genes were respectively related to immunity responses to infection, viral transcription and response to interferon-γ pathways, and perforin 1 and T-cell receptor B variable 9. CONCLUSIONS: Metagenomic DNA and RNA-seq can identify a wide range of LRTI pathogens, with improved sensitivity for viruses and fungi. Our in-host platform is likely feasible in the clinic. Host transcriptome data are expected to be useful for the diagnosis of LRTIs.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Chen H, Yin Y, Gao H, et al. Clinical Utility of In-house Metagenomic Next-generation Sequencing for the Diagnosis of Lower Respiratory Tract Infections and Analysis of the Host Immune Response. Clin Infect Dis. 2020. PMID: 33367583. doi:10.1093/cid/ciaa1516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。